After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...

Medical tech company BD (Becton, Dickinson and Co.) acquired MedKeeper, a provider of cloud-based pharmacy management applications, the Franklin Lakes firm announced July 28. The deal – terms of which ...

BD’s new MiniDraw diagnostic devices could let pharmacists—and, one day, maybe patients—manage blood testing needs and monitor health conditions. BD received its FDA authorizations for two blood draw ...

BD is recognized as one of the leading medical technology companies worldwide, with a substantial market capitalization of $59.35 billion and annual revenue exceeding $20.6 billion. The company is ...

After nearly a century spent building out its portfolio of insulin pens and syringes, BD is finally ready to let its diabetes care business leave the nest. While reporting financial results for the ...

Waters plans to combine with the Biosciences & Diagnostic Solutions business of BD (Becton, Dickinson & Co.), the companies said, in a $17.5 billion deal that would be the year’s largest within life ...

FRANKLIN LAKES, N.J., Feb. 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the successful completion of the previously announced spin-off of BD's Biosciences & ...

Dubai, United Arab Emirates – The Dubai branch of BD (Becton, Dickinson, and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will mark its presence at Arab ...

FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE:BDX) announced Tuesday it has commenced tender offers to purchase up to $1.6 billion aggregate purchase price of its outstanding debt ...